Business Name: |
Decesare II Raymond C MD |
Contact Person: |
Raymond Decesare II |
Address: |
401 Adams Avenue # 202, Scranton, Pennsylvania 18510 |
Phone Number: |
(570) 346-7338 |
Annual Revenue (USD): |
$1.000.000 to $2.499.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
Tereb Denis A MD - Scranton, PA 18510 Van Koch Lear MD - Scranton, PA 18510 Schreckengaust R J MD - Scranton, PA 18510 Monahan Mary Ellen MD - Scranton, PA 18510 Doherty John H MD - Scranton, PA 18510 Roche James J MD - Scranton, PA 18510 Gilbert Jerald B MD - Scranton, PA 18510 Stefanelli James L MD - Scranton, PA 18510 Jones Seth M MD - Scranton, PA 18510 Grandy John MD - Scranton, PA 18510 Drozdick III John MD - Scranton, PA 18510 Mc Nulty Kristine M MD - Scranton, PA 18510 Kolucki Jr Frank R MD - Scranton, PA 18510 Lundin John P MD - Scranton, PA 18510 Arora Subhash C MD - Scranton, PA 18510 Oncology Therapy Center - Scranton, PA 18510 Hartman C Richard MD - Scranton, PA 18510 Demko Joseph N MD - Scranton, PA 18510 Aronica Michael MD - Scranton, PA 18510 Galanakis Stylianos J MD - Scranton, PA 18510 |
The company Decesare II Raymond C MD provides B2C services in the form of Doctors from its single location in Pennsylvania.
1 to 4 employees work for Decesare II Raymond C MD, and the business now earns $1.000.000 to $2.499.999 per annum.
Decesare II Raymond C MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Decesare II Raymond C MD, please call Raymond Decesare II with the phone number (570) 346-7338 or visit its single location at 401 Adams Avenue # 202 in Scranton, Pennsylvania 18510.
The location of the single location can also be found using the coordinates 41.40994,-75.65923.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.